LOH rather than genotypes of TP53 codon 72 is associated with disease-free survival in primary breast cancer

Author： Kyndi Marianne Alsner Jan Lotte Hansen Lise Brandt Sørensen Flemming Overgaard Jens

ISSN： 0284-186X

Source： Acta Oncologica, Vol.45, Iss.5, 2006-07, pp. : 602-609

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Polymorphisms of the pri-miR-34b/c promoter and TP53 codon 72 are associated with risk of colorectal cancer

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 995-1002

Spandidos Publications

Access to resources Recommend Favorite

No significant association results obtained from significant association evidence: the ongoing uncertainty of TP53 codon 72 polymorphism and breast cancer risk

By Lu Pei-Hua

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 601-603

Springer Publishing Company

Access to resources Recommend Favorite

The p53 codon 72 polymorphism is associated with risk and early onset of breast cancer among Saudi women

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 875-878

Spandidos Publications

Access to resources Recommend Favorite

Genetic variants in the vitamin D pathway and breast cancer disease-free survival

By Pande Mala

Carcinogenesis, Vol. 34, Iss. 3, 2013-03 ,pp. : 587-594

Oxford University Press

Access to resources Recommend Favorite

p53 codon 72 polymorphism and breast cancer risk: A meta-analysis

Experimental and Therapeutic Medicine, Vol. 5, Iss. 5, 2013-01 ,pp. : 1397-1402

Spandidos Publications

Access to resources Recommend Favorite